India to Myanmar: Guaifenesin Export Trade Route
India has recorded 12 verified shipments of Guaifenesin exported to Myanmar, representing a combined trade value of $310.6K USD. This corridor is served by 6 active Indian exporters, with an average shipment value of $25.9K USD. The leading Indian exporter is EMCURE PHARMACEUTICALS LIMITED, which accounts for 41% of total export value with 4 shipments worth $128.8K USD. On the buying side, GRACE WIN CO.,LTD. is the largest importer in Myanmar with $81.7K USD in purchases. The top 3 suppliers — EMCURE PHARMACEUTICALS LIMITED, GENO PHARMACEUTICALS PRIVATE LIMITED, UNIVERSAL PHARMACEUTICALS PRIVATE LIMITED — together control 82% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Myanmar Guaifenesin corridor is one of India's established pharmaceutical export routes, with 12 shipments documented worth a combined $310.6K USD. The route is dominated by EMCURE PHARMACEUTICALS LIMITED, which alone accounts for roughly 41% of all export value, reflecting the consolidated nature of India's guaifenesin manufacturing sector.
Across 6 active suppliers, the average shipment value stands at $25.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during July–September, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 28.7%, placing it at rank #12 among India's top guaifenesin export destinations globally.
On the import side, key buyers of Indian guaifenesin in Myanmar include GRACE WIN CO.,LTD., NEBULA TRADING CO LTD, KHETAN COMPANY LIMITED and 6 others. GRACE WIN CO.,LTD. is the single largest importer with 2 shipments valued at $81.7K USD.
Route Characteristics
- Average transit17 days
- Peak seasonQ3
- Primary modeMulti-modal
- Top portJNPT
Market Position
- Global rank#12
- Annual growth+28.7%
- Demand growth+25.9%
- Regulatory ease70/100
Top 10 Indian Guaifenesin Exporters to Myanmar
Showing top 10 of 6 Indian suppliers exporting Guaifenesin to Myanmar, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EMCURE PHARMACEUTICALS LIMITED Avg $32.2K per shipment | 4 | $128.8K | 41.5% |
| 2 | GENO PHARMACEUTICALS PRIVATE LIMITED Avg $35.5K per shipment | 2 | $71.1K | 22.9% |
| 3 | UNIVERSAL PHARMACEUTICALS PRIVATE LIMITED Avg $18.7K per shipment | 3 | $56.2K | 18.1% |
| 4 | C AND C ORGANICS PRIVATE LIMITED Avg $31.4K per shipment | 1 | $31.4K | 10.1% |
| 5 | BLUE CROSS LABORATORIES PRIVATE LIMITED Avg $16.5K per shipment | 1 | $16.5K | 5.3% |
| 6 | JOINHUB PHARMA LLP Avg $6.6K per shipment | 1 | $6.6K | 2.1% |
This table shows the top 10 of 6 Indian companies exporting guaifenesin to Myanmar, ranked by total trade value. The listed exporters are: EMCURE PHARMACEUTICALS LIMITED, GENO PHARMACEUTICALS PRIVATE LIMITED, UNIVERSAL PHARMACEUTICALS PRIVATE LIMITED, C AND C ORGANICS PRIVATE LIMITED, BLUE CROSS LABORATORIES PRIVATE LIMITED , JOINHUB PHARMA LLP. EMCURE PHARMACEUTICALS LIMITED is the dominant supplier with 4 shipments worth $128.8K USD, giving it a 41% market share. The top 3 suppliers together account for 82% of the total trade value on this route.
Top 10 Guaifenesin Importers in Myanmar
Showing top 10 of 9 known buyers in Myanmar receiving Guaifenesin shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian guaifenesin in Myanmar include GRACE WIN CO.,LTD., NEBULA TRADING CO LTD, KHETAN COMPANY LIMITED, TO, VITAL PHARMACEUTICAL CO. LTD., K.T.Z COMPANY LTD, among 9 total buyers. The largest importer is GRACE WIN CO.,LTD., accounting for $81.7K USD across 2 shipments — representing 26% of all guaifenesin imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | GRACE WIN CO.,LTD. | 2 | $81.7K | 26.3% |
| 2 | NEBULA TRADING CO LTD | 2 | $71.1K | 22.9% |
| 3 | KHETAN COMPANY LIMITED | 2 | $47.1K | 15.2% |
| 4 | TO, VITAL PHARMACEUTICAL CO. LTD. | 1 | $31.4K | 10.1% |
| 5 | K.T.Z COMPANY LTD | 1 | $21.3K | 6.9% |
| 6 | K T Z COMPANY LIMITED | 1 | $18.8K | 6.0% |
| 7 | SIN PHYU KYUN COMPANY LIMITED | 1 | $16.5K | 5.3% |
| 8 | K T Z COMPANY LTD | 1 | $16.0K | 5.2% |
| 9 | M S MYINT MOH OO SHWE SIN CO LTD | 1 | $6.6K | 2.1% |
Top 10 Guaifenesin Formulations Imported by Myanmar
Showing top 10 of 11 product formulations shipped on the India to Myanmar Guaifenesin route, ranked by trade value
Myanmar imports a wide range of guaifenesin formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PHARMACEUTICAL PRODUCTS - VIFEX L SYRUP100ML ( LEVOSALBUTAMOL SULPHATE, AMBROXOL HYDROCHLORIDE & GUAIFENESIN SYRUP 0.5M — accounts for $81.7K USD across 1 shipments. There are 11 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PHARMACEUTICAL PRODUCTS - VIFEX L SYRUP100ML ( LEVOSALBUTAMOL SULPHATE, AMBROXOL HYDROCHLORIDE & GUAIFENESIN SYRUP 0.5M | 1 | $81.7K | 26.3% |
| 2 | RESPIRA LIQUID 100ML EACH 5ML CONTAINS SALBUTAMOL SULPHATE BP 1MG AMBROXOL HYDROCHLORIDE BP 15MG GUAIFENESIN BP 50MG MEN | 2 | $71.1K | 22.9% |
| 3 | PHARMACEUTICAL PRODUCTS - VIFEX SYRUP 100 ML BT ( SALBUTAMOL SULPHATE, BROMHEXINE HYDROCHLORIDE & GUAIFENESIN SYRUP 1MG/ | 1 | $47.1K | 15.2% |
| 4 | V-TUSSIN (DEXTROMETHORPHAN BROMHEXINE GUAIFENESIN CHLORPHENIRAMINE),B.NO.ETG25001 TO ETG25010,MFG.JAN-2025,EXP.DEC-2027 | 1 | $31.4K | 10.1% |
| 5 | PHARMACEUTICALS- MUCOROL-S LIQUID 100ML(AMBROXOL,SALBUTAMAL & GUAIFENESIN SYRUP) | 1 | $21.3K | 6.9% |
| 6 | PHARMACEUTICALS - MUCOROL-S LIQUID 100MLAMBROXOL SALBUTAMOL & GUAIFENESIN SYRUP | 1 | $18.8K | 6.0% |
| 7 | TUSQ Dx TABS 20 x 10's (Bulk Drug:Bromhexine Hydrochloride BP 8mg Guaifenesin BP100mg Phenylephrine Hydrochloride BP 5m | 1 | $16.5K | 5.3% |
| 8 | PHARMACEUTICALS MUCOROL S LIQUID 100ML AMBROXOL SALBUTAMOL GUAIFENESIN SYRUP | 1 | $16.0K | 5.2% |
| 9 | GUFADEX 10X10 TAB. DEXTROMETHORPHAN USP 15 MG, GUAIFENESIN USP 100 MG, TERPINHYDRATE USP 200 MG - AS PER DOCUMENT | 1 | $6.6K | 2.1% |
| 10 | FOC : PHARMACEUTICAL PRODUCTS - VIFEX SYRUP 100 ML BT ( SALBUTAMOL SULPHATE, BROMHEXINE HYDROCHLORIDE & GUAIFENESIN SYRU | 1 | $1 | 0.0% |
Showing top 10 of 11 Guaifenesin formulations imported by Myanmar on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 69% sea for bulk, 18% air for urgent orders.
Top Ports of Origin
JNPT handles the highest volume with 3 shipments. Transit time averages 17 days by sea.
Market Dynamics
India's guaifenesin exports to Myanmar are driven primarily by a handful of large-scale manufacturers. EMCURE PHARMACEUTICALS LIMITED with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in Myanmar benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — EMCURE PHARMACEUTICALS LIMITED, GENO PHARMACEUTICALS PRIVATE LIMITED, UNIVERSAL PHARMACEUTICALS PRIVATE LIMITED — together account for 82% of total trade value on this route. The average shipment value of $25.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as respira liquid 100ml each 5ml contains salbutamol sulphate bp 1mg ambroxol hydrochloride bp 15mg guaifenesin bp 50mg men and pharmaceutical products - vifex syrup 100 ml bt ( salbutamol sulphate, bromhexine hydrochloride & guaifenesin syrup 1mg/, suggesting that buyers in Myanmar tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, GRACE WIN CO.,LTD. is the largest importer with 2 shipments worth $81.7K USD — representing 26% of all guaifenesin imports from India on this route. A total of 9 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $310.6K
- Avg. Shipment
- $25.9K
- Suppliers
- 6
- Buyers
- 9
- Transit (Sea)
- ~17 days
- Annual Growth
- +28.7%
Related Analysis
Other Guaifenesin Routes
Unlock the Full India to Myanmar Guaifenesin Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 12 shipments on this route.
Frequently Asked Questions — India to Myanmar Guaifenesin Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Guaifenesin to Myanmar?
The leading Indian exporters of Guaifenesin to Myanmar are EMCURE PHARMACEUTICALS LIMITED, GENO PHARMACEUTICALS PRIVATE LIMITED, UNIVERSAL PHARMACEUTICALS PRIVATE LIMITED. EMCURE PHARMACEUTICALS LIMITED holds the largest market share at approximately 41% of total trade value on this route.
Q What is the total value of Guaifenesin exports from India to Myanmar?
India exports Guaifenesin to Myanmar worth approximately $310.6K USD across 12 recorded shipments. The average value per shipment is $25.9K USD.
Q Which ports does India use to ship Guaifenesin to Myanmar?
The most active port of origin is JNPT with 3 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 69% of shipments going by sea and 18% by air.
Q How long does shipping take from India to Myanmar for Guaifenesin?
The average transit time for Guaifenesin shipments from India to Myanmar is approximately 17 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to Myanmar Guaifenesin trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 28.7% with demand growth tracking at 25.9%. The route is ranked #12 among India's top Guaifenesin export destinations globally.
Q How many suppliers are active on the India to Myanmar Guaifenesin route?
There are currently 6 active Indian suppliers exporting Guaifenesin to Myanmar. The market is moderately concentrated with EMCURE PHARMACEUTICALS LIMITED accounting for 41% of total shipment value.
Q Who are the main importers of Guaifenesin from India in Myanmar?
The leading importers of Indian Guaifenesin in Myanmar include GRACE WIN CO.,LTD., NEBULA TRADING CO LTD, KHETAN COMPANY LIMITED, TO, VITAL PHARMACEUTICAL CO. LTD., K.T.Z COMPANY LTD. GRACE WIN CO.,LTD. is the largest buyer with 2 shipments worth $81.7K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Myanmar export trade corridor identified from Indian Customs (DGFT) records for Guaifenesin.
- 2.Supplier/Buyer Matching: 6 Indian exporters and 9 importers in Myanmar matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 12 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
12 Verified Shipments
6 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists